Alerts will be sent to your verified email
Verify Email
KAPPAC PHARM
|
Kappac Pharma
|
|
|---|---|
|
Operational Metrics
|
|
|
Financials
|
|
|
5 yr Average ROE
|
-0.23 % |
|
5yr average Equity Multiplier
|
1.04 |
|
5yr Average Asset Turnover Ratio
|
0.0 |
|
5yr Avg Net Profit Margin
|
0.0 |
|
Price to Book
|
9.43 |
|
P/E
|
0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 |
|
Inventory Days
|
0.0 |
|
Days Receivable
|
0.0 |
|
Days Payable
|
0.0 |
|
5yr Average Interest Coverage Ratio
|
-2260.1 |
|
5yr Avg ROCE
|
-0.23 % |
|
5yr Avg Operating Profit Margin
|
0.0 |
|
5 yr average Debt to Equity
|
0.03 |
|
5yr CAGR Net Profit
|
51.57 % |
|
5yr Average Return on Assets
|
-0.22 % |
|
Shareholdings
|
|
|
Promoter Holding
|
0.0 |
|
Share Pledged by Promoters
|
0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 |
|
Kappac Pharma
|
|---|